Results 41 to 50 of about 19,811 (179)

First literature review of carbapenem-resistant Providencia

New Microbes and New Infections, 2018
Providencia species are Gram-negative bacteria that belong to the Enterobacteriaceae family. They have intrinsic resistance to colistin and tigecycline, which makes treatment of the multidrug-resistant strains of Providencia challenging.
M. Abdallah, A. Balshi
doaj   +1 more source

Clinical Risk Factors and Microbiological and Intestinal Characteristics of Carbapenemase-Producing Enterobacteriaceae Colonization and Subsequent Infection

Microbiology Spectrum, 2022
Gastrointestinal colonization with carbapenem-resistant Enterobacteriaceae (CRE) is always a prerequisite for the development of translocated infections.
Wenli Yuan, Jiali Xu, Lin Guo, Yonghong Chen, Jinyi Gu, Huan Zhang, Chenghang Yang, Qiuping Yang, Shuwen Deng, Longlong Zhang, Qiongfang Deng, Zi Wang, Bin Ling, Deyao Deng   +13 more
doaj   +1 more source

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae

New England Journal of Medicine, 2019
Plazomicin for Severe Resistant Infection This report compared plazomicin with colistin for the treatment of severe (bloodstream or pneumonia) infection with carbapenem-resistant Enterobacteriaceae...
McKinnell, J.A., Dwyer, J.P., Talbot, G.H., Connolly, L.E., Friedland, I., Smith, A., Jubb, A.M., Serio, A.W., Krause, K.M., Daikos, G.L.   +9 more
openaire   +3 more sources

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

Brazilian Journal of Infectious Diseases, 2017
This study evaluated the in vitro activity of ceftolozane-tazobactam and comparator agents tested against Latin American isolates of Enterobacteriaceae and Pseudomonas aeruginosa from patients with health care-associated infections.
Michael A. Pfaller, Dee Shortridge, Helio S. Sader, Ana Gales, Mariana Castanheira, Robert K. Flamm   +5 more
doaj   +1 more source

Factors associated with acquisition of carbapenem-resistant Enterobacteriaceae [PDF]

Revista Latino-Americana de Enfermagem, 2017
ABSTRACT Objective: to identify possible risk factors for acquisition of Enterobacterial strains with a marker for resistance to carbapenems. Methods: exploratory case-control study performed in hospital settings. The study sample consisted of patients with biological specimens that tested positive for carbapenem-resistant Enterobacteriaceae (cases ...
Lavagnoli, Lilian Silva, Bassetti, Bil Randerson, Kaiser, Thais Dias Lemos, Kutz, Kátia Maria, Cerutti Junior, Crispim   +4 more
openaire   +4 more sources

Detection of Klebsiella pneumoniae Carbapenemase (KPC) Producing Enterobacteriaceae Isolates from Various Clinical Samples in a Rural Health Setup

Journal of Pure and Applied Microbiology, 2020
Carbapenem resistance is increasing and emerging as a public health threat. The Indian subcontinent serves as a reservoir for all 3 types of carbapenemases: KPC, OXA-181 and NDM. The present study was done to determine the antibiotic resistance pattern
Arveen Sokhi, Priti Agarwal, Megha Maheshwari, Anita Chakravarti   +3 more
doaj   +1 more source

Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan

Journal of Microbiology, Immunology and Infection, 2022
Background: Imipenem-relebactam is a new β-lactam and β-lactamase inhibitor combination to treat carbapenem-resistant gram-negative bacteria infections. However, difference in carbapenem resistant mechanisms existed with geographic variations. Objective:
Tsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, Guan Hong Liu, Shao-Hsuan Lian, Liang-Chun Wang, I-Ling Lin, Hsian-Yu Wang, Sung-Pin Tseng, Po-Liang Lu   +9 more
doaj   +1 more source

Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis

Brazilian Journal of Infectious Diseases, 2015
In recent years, carbapenem-resistant Enterobacteriaceae has become endemic in many countries. Because of limited treatment options, the abandoned “old antibiotics”, polymyxins, have been reintroduced to the clinic.
Wentao Ni, Xuejiu Cai, Chuanqi Wei, Xiuzhen Di, Junchang Cui, Rui Wang, Youning Liu   +6 more
doaj   +1 more source

Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant Enterobacteriaceae

Annals of Medicine, 2022
Introduction Occurrence of colistin-resistant Enterobacteriaceae in response to the unregulated use of this antibiotic has been documented. This study reports an investigation of colistin resistance rates among carbapenem-resistant enterobacterial ...
Hadir A. El-Mahallawy, Marwa El Swify, Asmaa Abdul Hak, Mai M. Zafer   +3 more
doaj   +1 more source

Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects [PDF]

Frontiers in Microbiology, 2018
Carbapenem-resistant Enterobacteriaceae (CRE), a major resistance concern emerging during the last decade because of significantly compromising the efficacy of carbapenem agents, has currently become an important focus of infection control. Many investigations have shown a high association of CRE infections with high case-fatality rates.
Shio-Shin Jean, Shio-Shin Jean, Nan-Yao Lee, Hung-Jen Tang, Hung-Jen Tang, Min-Chi Lu, Wen-Chien Ko, Po-Ren Hsueh, Po-Ren Hsueh   +8 more
openaire   +4 more sources